Swiss Infrastructure Stock News

SWX:NWRN
SWX:NWRNPharmaceuticals

Did Launching the ENIGMA-TRS 2 Phase III Trial Just Shift Newron Pharmaceuticals' (SWX:NWRN) Investment Narrative?

Newron Pharmaceuticals has initiated its ENIGMA-TRS 2 global Phase III trial of evenamide as an add-on therapy for treatment-resistant schizophrenia, following US FDA and IRB approvals, with the first site at UCLA’s Semel Translational Research Center for Neuropsychiatry. The study’s focus on rigorously defined treatment-resistant patients and evenamide’s targeted sodium-channel mechanism highlights its potential differentiation from existing antipsychotic options. Next, we’ll explore how...
SWX:BYS
SWX:BYSMachinery

European Stocks Estimated Below Fair Value In December 2025

As European markets show mixed returns with the STOXX Europe 600 Index inching higher on hopes of interest rate cuts, investors are keenly observing economic indicators such as inflation and GDP revisions. In this environment, identifying undervalued stocks can be a strategic move, as these equities may offer potential for growth when market conditions stabilize.
SWX:LLBN
SWX:LLBNBanks

Top European Dividend Stocks To Consider In December 2025

As European markets continue to show resilience, with the STOXX Europe 600 Index climbing 2.35% and major single-country indexes also posting gains, investors are increasingly looking toward dividend stocks as a stable income source amid subdued inflation rates across the eurozone. In this environment, selecting stocks that offer reliable dividend yields can be an effective strategy for those seeking consistent returns while navigating the current economic landscape.
SWX:CMBN
SWX:CMBNConsumer Finance

European Dividend Stocks To Watch Now

As European markets experience a positive upswing, with the STOXX Europe 600 Index rising by 2.35%, investors are keenly observing the region's economic landscape, particularly as inflation appears to align closely with the European Central Bank’s target. In this context, dividend stocks can offer attractive opportunities for income-focused investors seeking stability and potential growth in a market characterized by subdued inflation and strategic fiscal adjustments.